We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$118B
AUM Growth
+$8.59B
Cap. Flow
-$401M
Cap. Flow %
-0.34%
Top 10 Hldgs %
16.92%
Holding
8,702
New
1,333
Increased
3,126
Reduced
2,721
Closed
1,293

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$346M
2
AVGO icon
Broadcom
AVGO
+$326M
3
BA icon
Boeing
BA
+$263M
4
COF icon
Capital One
COF
+$258M
5
OXY icon
Occidental Petroleum
OXY
+$257M

Sector Composition

Rank Sector Weight
1 Technology 7.15%
2 Financials 5.56%
3 Consumer Discretionary 5.28%
4 Industrials 4.73%
5 Healthcare 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASX icon
7276
ASE Group
ASX
$82.2B
-34,326
Closed -$222K
CVSA
7277
CALL
Covista Inc
CVSA
$4.8B
-9,000
Closed -$319K
ATR icon
7278
AptarGroup
ATR
$8.61B
-33,195
Closed -$2.56M
ATOS icon
7279
Atossa Therapeutics
ATOS
$23.5M
-64
Closed -$9K
ATXS
7280
DELISTED
Astria Therapeutics
ATXS
-466
Closed -$45K
AVAV icon
7281
PUT
AeroVironment
AVAV
$9.45B
-11,900
Closed -$334K
AVXL icon
7282
Anavex Life Sciences
AVXL
$310M
-16,293
Closed -$94.2K
AWX icon
7283
Avalon Holdings
AWX
$10.1M
-10,882
Closed -$25K
AX icon
7284
Axos Financial
AX
$5.68B
-7,975
Closed -$189K
AXTI icon
7285
CALL
AXT Inc
AXTI
$5.8B
-12,300
Closed -$71K
AZZ icon
7286
PUT
AZZ Inc
AZZ
$4.54B
-5,000
Closed -$298K
BAH icon
7287
CALL
Booz Allen Hamilton
BAH
$9.15B
-10,600
Closed -$375K
BATRK icon
7288
Atlanta Braves Holdings Series B
BATRK
$3.21B
-17,729
Closed -$419K
BBD icon
7289
Banco Bradesco
BBD
$36.7B
-129,951
Closed -$659K
BBDC icon
7290
CALL
Barings BDC
BBDC
$965M
-29,600
Closed -$565K
BBDC icon
7291
Barings BDC
BBDC
$965M
-11,552
Closed -$221K
BBP icon
7292
Virtus Biotech ETF
BBP
$100M
-12,453
Closed -$470K
BCC icon
7293
Boise Cascade
BCC
$3.02B
-82,933
Closed -$2.42M
BCE icon
7294
BCE
BCE
$21.2B
-79,597
Closed -$3.59M
BCLI
7295
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
-1,158
Closed -$71.4K
BFOR icon
7296
Barron's 400 ETF
BFOR
$239M
-35,388
Closed -$324K
BGFV
7297
CALL
DELISTED
Big 5 Sporting Goods
BGFV
-16,100
Closed -$243K
BGS icon
7298
CALL
B&G Foods
BGS
$286M
-9,000
Closed -$362K
BIP icon
7299
Brookfield Infrastructure Partners
BIP
$18B
-19,807
Closed -$456K
BIS icon
7300
CALL
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.1M
-1,025
Closed -$228K

Similar funds

Citadel Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Citadel Advisors held 8,702 positions worth $118B, up 7.8% from $109B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citadel Advisors's Q2 2017 filing shows 1,333 new, 3,126 increased, 2,721 reduced and 1,293 closed positions. Its largest new stake was Equity Residential: 2,436,064 shares worth $160M. The largest sale was Walt Disney, an estimated $550M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 7.1% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Citadel Advisors's largest Q2 2017 buy was Equity Residential: 2,436,064 shares worth $160M.
  • Citadel Advisors added most to Applied Materials in Q2 2017, an estimated $346M increase.
  • Citadel Advisors's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $549M.
  • Citadel Advisors fully exited Walt Disney in Q2 2017, selling an estimated $550M.
  • Citadel Advisors's ten largest holdings make up 17% of its $118B portfolio in Q2 2017.
  • Citadel Advisors opened 1,333 new positions and closed 1,293 in Q2 2017.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $118B.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.